Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Biogen files with FDA for approval of Alzheimer's therapy
Biogen has requested priority review for Alzheimer's disease therapy aducanumab, which could speed the medication's path to market.
